T1	Pharmacodynamic_phenotype	0 34	Acquired resistance to vemurafenib
T2	Phenotype	51 81	reactivation of MAPK signaling
T3	Phenotype	106 138	ERK1/2 phosphorylation levels in
T4	Limited_variation	193 220	AS ( Q61 ) mutations or MEK
T5	Limited_variation	224 258	Q56P ) or MEK1(E203K ) mutations .
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T2	Arg2:T1
R6	isAssociatedWith	Arg1:T2	Arg2:T3
R7	isAssociatedWith	Arg1:T2	Arg2:T4
R8	isAssociatedWith	Arg1:T2	Arg2:T5
R9	isAssociatedWith	Arg1:T3	Arg2:T1
R10	isAssociatedWith	Arg1:T3	Arg2:T2
R11	isAssociatedWith	Arg1:T3	Arg2:T4
R12	isAssociatedWith	Arg1:T3	Arg2:T5
R13	isAssociatedWith	Arg1:T4	Arg2:T1
R14	isAssociatedWith	Arg1:T4	Arg2:T2
R15	isAssociatedWith	Arg1:T4	Arg2:T3
R16	isAssociatedWith	Arg1:T4	Arg2:T5
R17	isAssociatedWith	Arg1:T5	Arg2:T1
R18	isAssociatedWith	Arg1:T5	Arg2:T2
R19	isAssociatedWith	Arg1:T5	Arg2:T3
R20	isEquivalentTo	Arg1:T5	Arg2:T4
